KalVista Pharmaceuticals ... (KALV)
10.85
-0.54 (-4.78%)
At close: Mar 03, 2025, 3:59 PM
10.87
0.18%
After-hours: Mar 03, 2025, 04:00 PM EST
KalVista Pharmaceuticals Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -126.64M | -92.91M | -82.34M | -46.24M | -29.12M | -20.82M | -15.8M | -18.6M | -11.44M | -7.23M | -5.68M | -2.05M |
| Depreciation & Amortization | 816K | 718K | 564K | 537K | 512K | 378K | 180K | 40K | 33K | 38K | 27K | 38K |
| Stock-Based Compensation | 21.91M | 9.92M | 11.09M | 7.12M | 4.45M | 2.97M | 1.06M | 394K | 118K | 36K | 238K | 47K |
| Other Working Capital | 2.67M | 6.31M | -14.01M | 8.2M | -19.64M | -20.32M | 25.56M | -2.58M | -584K | 617K | 145K | 43K |
| Other Non-Cash Items | -485K | 84K | 4.88M | 114K | 13K | -103K | -651K | -1.37M | -1.66M | 167.00 | 32K | 104K |
| Deferred Income Tax | n/a | -491K | n/a | -42K | -33K | n/a | n/a | n/a | n/a | n/a | 63K | -6K |
| Change in Working Capital | 15.17M | 7.41M | -12.32M | 8.35M | -20.64M | -18.79M | 25.77M | -4.18M | -210K | 784K | 460K | 35K |
| Operating Cash Flow | -89.23M | -75.26M | -78.13M | -30.17M | -44.82M | -36.37M | 10.56M | -23.72M | -13.16M | -6.37M | -4.86M | -1.83M |
| Capital Expenditures | -443K | -1.2M | -931K | -82K | -220K | -1.08M | -1.43M | -74K | -11K | -125K | -18K | -91K |
| Acquisitions | n/a | -57.86M | -57.86M | 147.65M | -16.75M | 69.42M | n/a | 34.14M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -189.23M | -98.25M | -136.92M | -201.21M | -49.8M | -79.89M | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 104.95M | 140.86M | 195.71M | 53.64M | 66.77M | 11.55M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -443K | 57.86M | 57.86M | -147.65M | 16.75M | -69.42M | -1.43M | 34.14M | -715K | n/a | n/a | n/a |
| Investing Cash Flow | -84.72M | 41.41M | 57.86M | -147.65M | 16.75M | -69.42M | -1.43M | 34.06M | -11K | -125K | -18K | -91K |
| Debt Repayment | n/a | n/a | n/a | n/a | -54K | -209K | -151K | n/a | n/a | n/a | 388K | -389K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 53.77M | 1.53M | 1.58M | 1.53M | 216K | 242K | n/a | 2K | 66M | 17.32M | 6.01M | 5.95M |
| Financial Cash Flow | 150.71M | 58.12M | 1.58M | 212.12M | 11.58M | 87.94M | 8.99M | 2K | 33M | 8.66M | 6.42M | 5.56M |
| Net Cash Flow | -24.45M | 25.51M | -19.86M | 34.8M | -16.22M | -19.05M | 20.11M | 9.19M | 19.24M | 2.04M | 1.54M | 3.64M |
| Free Cash Flow | -89.67M | -76.46M | -79.06M | -30.25M | -45.04M | -37.45M | 9.13M | -23.8M | -13.17M | -6.49M | -4.88M | -1.93M |